Stage IIB Cervical Cancer AJCC v6 and v7

specific

Stage IIIB includes: (T3b, Any N, M0); (T1-3, N1, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)

66

Centers

48

Active Trials

Cancer Funding

Top Centers for Stage IIB Cervical Cancer AJCC v6 and v7(66)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
56.9
2
NCI Comprehensive
Active Research Program
56.9
3
NCI Comprehensive
Active Research Program
56.9
4
NCI Comprehensive
Active Research Program
56.9
5
NCI Comprehensive
Active Research Program
56.9
6
NCI Comprehensive
Active Research Program
56.9
7
NCI Comprehensive
Active Research Program
56.9
8
NCI Comprehensive
Active Research Program
56.9
9
NCI Comprehensive
Active Research Program
56.9
10
NCI Comprehensive
Active Research Program
56.9
1156.9
12
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
56.9
13
NCI Comprehensive
Active Research Program
56.9
14
NCI Comprehensive
Active Research Program
56.9
15
NCI Comprehensive
Active Research Program
56.9
16
NCI Comprehensive
Active Research Program
56.9
17
NCI Comprehensive
Active Research Program
56.9
18
NCI Comprehensive
Active Research Program
56.9
19
NCI Clinical
Active Research Program
56.9
20
NCI Comprehensive
Active Research Program
56.9
21
NCI Comprehensive
Active Research Program
56.9
22
NCI Comprehensive
Active Research Program
56.9
23
NCI Comprehensive
Active Research Program
56.9
24
NCI Clinical
Active Research Program
56.9
25
NCI Comprehensive
Active Research Program
56.9
26
Active Research Program
56.9
27
Active Research Program
56.9
28
NCI Comprehensive
Active Research Program
56.9
29
NCI Clinical
Active Research Program
56.9
30
NCI Comprehensive
Active Research Program
56.9
31
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
56.9
32
Active Research Program
56.9
33
NCI Clinical
Active Research Program
56.9
34
NCI Comprehensive
Active Research Program
56.9
35
Active Research Program
56.9
36
NCI Comprehensive
Active Research Program
56.9
3756.9
38
Active Research Program
56.9
39
NCI Basic_laboratory
Active Research Program
56.9
40
Active Research Program
56.9
41
Active Research Program
56.9
42
Active Research Program
56.9
43
Active Research Program
56.9
44
Active Research Program
56.9
4556.9
46
Active Research Program
56.9
47
Active Research Program
56.9
48
Active Research Program
56.9
49
NCI Comprehensive
34.4
5034.4
51
NCI Comprehensive
34.4
52
NCI Comprehensive
34.4
53
NCI Comprehensive
34.4
54
NCI Comprehensive
34.4
5534.4
5634.4
57
NCI Clinical
34.4
58
NCI Comprehensive
34.4
59
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
34.4
6034.4
6134.4
6234.4
6334.4
6434.4
65
BC CancerVancouver, BC
34.4
6634.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →